Race Oncology June 2022 Quarterly Investor Briefing

preview_player
Показать описание
Race Oncology CEO Phillip Lynch and CSO Dr Daniel Tillett present Race's June 2022 Quarterly Investor Briefing followed by a Q&A session. In this video they discuss the Company’s recent progress and key highlights from the quarter, before taking questions from investors.

Рекомендации по теме